The National Comprehensive Cancer Network (NCCN) has published new guidelines and a “quick guide” series to better inform chronic lymphocytic leukemia (CLL) and Hodgkin’s lymphoma patients about the best treatment options now available for their disease. The two are the latest additions to the NCCN’s library of resources for people with blood and other cancers.
Additionally, the NCCN recently published a quick guide for chronic myelogenous leukemia (CML) patients.
Due to clinical advances over the last 30 years, Hodgkin’s lymphoma is a rare but curable disease insome 80 percent of cases, with unmatched five-year survival rates among cancer patients. Both NCCN Guidelines for Patients and its Quick Guide series for Hodgkin’s lymphoma has been divided into three sections to provide users with more targeted information on a diagnosis: an overview of the disease’s treatment, a definition of classical Hodgkin’s lymphoma, and a chapter on nodular lymphocyte-predominant Hodgkin’s lymphoma.
The NCCN is a nonprofit alliance of 26 leading cancer centers that focus on care, research and education. With the help of professionals at its member institutions, the NCCN develops clinical practice guidelines and resources crafted with patients, caregivers, and others without a science or medical background in mind.
The NCCN Guidelines for Patients are translations of the Clinical Practice Guidelines in Oncology, designed to provide people with cancer diagnoses, and their caregivers, with updated information in easy-to-understand language. The guidelines are written by multidisciplinary teams of NCCN experts and address appropriate management options, from initial diagnosis to the disease progression. The resources aim to educate patients on health literacy and include patient-friendly elements, like medical illustrations of anatomy, tests, and treatments. They also feature comprehensive glossaries of terms and acronyms relevant to a given disease.
“Through providing free resources for people with these blood cancers, NCCN Foundation strives to empower patients by providing insight into their treatment options, allowing them to work alongside their care team to make informed decision about their care,” Marcie R. Reeder, MPH, the NCCN Foundation’s executive director, said in a press release.
More information, including access to the guidelines and quick guides, are available through this link.
